Daniel Seaboldt
About Daniel Seaboldt
Daniel Seaboldt is an Art Supervisor with extensive experience in publication design and typography. He has worked at BGB Group since 2019 and previously at Sudler & Hennessey, contributing to various therapeutic categories and collaborating with notable clients in the healthcare sector.
Work at BGB Group
Daniel Seaboldt has been employed at BGB Group as an Art Supervisor since 2019. In this role, he oversees various art projects and contributes to the creative direction of the agency. His responsibilities include managing design teams and ensuring that the visual elements align with client objectives. BGB Group is known for its focus on healthcare marketing, which complements Seaboldt's extensive experience in therapeutic categories.
Previous Experience at Sudler & Hennessey
Before joining BGB Group, Daniel Seaboldt worked at Sudler & Hennessey as an Art Supervisor from 2010 to 2018. During his eight years with the company, he developed a strong portfolio in healthcare marketing. His role involved collaborating with various teams to create impactful visual content for clients in the pharmaceutical industry.
Education and Expertise
Daniel Seaboldt studied at the School of Visual Arts, where he gained foundational skills in art and design. He specializes in publication design and typography, which are critical components of his work in healthcare marketing. His educational background supports his ability to create effective visual communications across various media.
Artistic Contributions and Exhibitions
Daniel Seaboldt's artwork has been displayed at the Master Eagle Gallery in New York, showcasing his artistic talents to a broader audience. Additionally, his work has been archived in Carnegie Hall, indicating recognition within the art community. These exhibitions reflect his commitment to the arts and contribute to his professional profile.
Client Collaborations and Therapeutic Focus
Throughout his career, Daniel Seaboldt has collaborated with numerous clients, including Cubist, Genentech, Roche, Allergan, Forest, AstraZeneca, Alexion, and Novartis. He has created work across a wide range of therapeutic categories, such as oncology, neurology, infectious disease, cardiovascular disease, dermatology, and hematology. This diverse experience highlights his ability to adapt his design skills to meet the needs of various healthcare sectors.